“Clinical Response to Rifaximin Amongst Irritable Bowel Syndrome (IBS) Patients at Tertiary Level Hospital in Nepal”. Journal of Patan Academy of Health Sciences 11, no. 1 (June 14, 2024): 21–26. Accessed July 9, 2026. https://nepjol.info/index.php/JPAHS/article/view/65652.